Triple Negative Breast Cancer Treatment Market will exhibit a CAGR of around 5% over the forecast period 2020 to 2030
(1) NEW YORK, Dec. 16, 2020 /PRNewswire/ -- Significant rise in awareness about preventative therapies is anticipated to drive the triple-negative breast cancer treatment market during the forecast period. According to WHO, the risk of developing cancer before the age of 75 years is around 20.2% and that of dying from cancer before the age of 75 years is around 10.6%. According to the American Cancer Society, in 2019, around 268,600 new cases of invasive breast cancer were diagnosed among women...
New York United States Kostenloser Wertpapierhandel Rajendra Singh Us Sales Office Life Sciences Transformational Health
Source: finanznachrichten.de